谷歌浏览器插件
订阅小程序
在清言上使用

Efficacy and Safety of Switching to Dolutegravir with Boosted Darunavir in Virologically Suppressed Adults with HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: the DUALIS Study

Open forum infectious diseases(2020)

引用 16|浏览15
暂无评分
关键词
darunavir,dolutegravir,efficacy and safety,switch,HIV
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要